1.
Efficacy of olaparib in advanced cancers with germline or somatic mutations in BRCA1, BRCA2, CHEK2 and ATM, a Belgian Precision tumor-agnostic phase II study
2.
Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT)
3.
#243 Patterns and trends in the clinical practice of corpus uteri cancer in Belgium: an analysis of the effect database
Practice patterns, time trends and quality of care of uterine cancer in Belgium: An analysis of the EFFECT database.
Completeness and selection bias of a Belgian multidisciplinary, registration-based study on the EFFectiveness and quality of Endometrial Cancer Treatment (EFFECT).
4.
5.
6.
7.